Molecular epidemiology: Issues in study design and statistical analysis

Annals of the Academy of Medicine Singapore

Volumn 25, Issue 1, 1996, Pages 55-63

  Chia, K S ^a   Shi, C Y ^a   Lee, J ^b   Seow, A ^a   Lee, H P ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Biomarkers of effect; Biomarkers of exposure; Biomarkers of susceptibility; Confounding factors; Effect modifiers; Nested case control studies; Repeated measurements

Indexed keywords

BIOLOGICAL MARKER;

EPIDEMIOLOGY; HUMAN; METHODOLOGY; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICS;

BIOLOGICAL MARKERS; EPIDEMIOLOGY, MOLECULAR; HUMANS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY;

EID: 0029691804     PISSN: 03044602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Taubes G. Epidemiology faces its limits. Science 1995; 269:164-9.
2. Higginson J. The role of the pathologist in environmental medicine and public health. Am J Pathol 1977; 86:459-84.
3. Perera F P, Weinstein I B. Molecular epidemiology and carcinogen-DNA adduct detection: New approaches to the studies of human cancer causation. J Chron Dis 1982; 35:581-600.
4. Peto R. The need for ignorance in cancer research. In: Duncan R, Weston-Smith M, editors. The Encyclopedia of Medical Ignorance. Oxford: Pergammon Press, 1984:129-33.
5. Schulte P A, Rothman N, Schottenfeld D. Design considerations in molecular epidemiology. In: Schulte P A, Perera FP, editors. Molecular Epidemiology: Principles and Practices. Sandiago: Academic Press, 1993:159-98
6. Perera F P, Santella R M, Brenner D, Poirier M C, Munshi A A, Fischman H K, et al. DNA adducts, protein adducts and sister chromatid exchange in cigarette smokers and nonsmokers. J Natl Cancer Inst 1987; 79:449-56.
7. Weston A, Wiley J C, Manchester D K, Wilson V L, Brooks B R, Choi J S, et al Dosimeters of human carcinogen exposure: polycyclic aromatic hydrocarbon macromolecular adducts. In. Bartsch H, Hemminiki K, O'Neil I K, editors. Methods for Detecting DNA Damaging Agents in Humans. Applications in Cancer Epidemiology and Prevention. Lyon, France: IARC, 1988:439-50
8. Philips D H, Hewer A, Grover P L. Aromatic DNA adducts in human bone marrow and peripheral leucocytes. Carcinogenesis 1986; 7:2071-5.
9. Brogger A, Hagmar L, Hansteen I L, Heim S, Hogstedt B, Knudsen L, et al. An inter-Nordic prospective study on cytogenetic endpoints and cancer risk. Cancer Genet Cytogenet 1990; 45:85-92.
10. Zegar S L, Liang K Y. An overview of methods for the analysis of longitudinal data. Stat Med 1992, 11.1825-39.
11. Thomson S G. A method of a nalysis of laboratory data in an epidemiological study where time trends are present. Stat Med 1983; 2:147-53.
12. Bissell A F. Cusum techniques for quality control. Appl Stat 1969; 18:1-30.
13. North W R S. The quangle a modification of the cusum chart Appl Stat 1982; 31.155-8.
14. Rosenow E C III, Carr D T. Bronchogenic carcinoma. CA Cancer J Clin 1979; 29:233-46.
15. Suzuki H, Takahashi T, Kuroishi T, Suyama M, Ariyoshi Y, Ueda R. Cancer Res 1992; 52:734-6.
16. Bressac G, Kew M, Wands J, Osturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991; 350:429-31.
17. Hsu I, Metcalf R, Sun T, Welsh J, Wang N, Harris C C. Mutational hot spot in the p53 gene in human hepatocellular carcinomas. Nature 1991; 350:427-8.
18. Miettinen O S M. Design options in epidemiologic research an update. Scand J Work Environ Health 1982; 8(Suppl 1) 7-14.
19. Winn D M, Gunter E W. Biological specimen banks: a resource for molecular epidemiologic studies. In: Schulte P A, Perera F P, editors. Molecular Epidemiology: Principles and Practices. Sandiago: Academic Press, 1993:217-34.
20. Winn D M, Reichman M E, Gunter E W. Epidemiologic issues in the design and use of biologic specimen banks. Epidemiol Rev 1990; 12:56-70.
21. Petrakis N L. Biologic banking in cohort studies, with special reference to blood. Natl Cancer Inst Monogr 1985; 7:193-8.
22. Ross R K, Yuan J M, Yu M C, Wogan G N, Qian G S, Tu J D, Groopman J D, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992, 339.943-6.
23. Groopman J D, Jianqi Z, Donahue P R, Pikul A, Lisheng Z, Jun-shi C, et al. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guanzxi Autonomous Region, People's Republic of China. Cancer Res 1992; 46:4178-83
24. Willett W C, Morris S J, Pressel S, Taylor J O, Polk B F, Stampfer M J, et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983; ii:130-4.
25. Rothman K. Modern Epidemiology. Boston: Little, Brown and Company, 1986:178-220.
26. Anderson S, Auquier A. Statistical Methods for Comparative Studies: Techniques for Bias Reduction New York: John Wiley and Sons, 1980.
27. Rubin D B. The use of matched sampling and regression adjustment to remove bias in observational studies. Biometrics 1973; 29:185-203
28. Lee J, Lee H P. A situation in which age-adjustment by analysis of covariance may be inappropriate. Int J Epidemiol 1989; 18.280.
29. Lee J, Lee H P, Wilkens L. Comparing means by generalized matched sampling Psychiatry Res 1994; 54:305-6.
30. Archibald C, Lee H P. Sample size estimation for clinicians. Ann Acad Med Singapore 1995; 24:328-32.
31. Dupont W D, Plummer W D. Power and sample size calculations. Controlled Clin Trials 1990; 11:116-8.
32. Bloch D A. Sample size requirement and the cost of a randomized clinical trial with repeated measurements Stat Med 1986; 5:663-7.
33. Liu K J, Cumberland W G Sample size requirements for repeated measurements in continuous data. Stat Med 1992, 11:633-41.
34. Lee J, Koh D, Ong C N. Statistical evaluation of agreement between two methods for measuring a quantitative variable. Comput Biol Med 1989; 19 61-70.
35. Lee J Evaluating agreement between two methods for measuring the same quantity: a response Comput Biol Med 1992; 22:369-71.
36. Linnett K. Estimation of the linear relationship between the measurement of two methods with proportional errors. Stat Med 1990, 9:1463-74.
37. Lee J, Fung K P, Lee H F. A statistical method to evaluate the precision of an instrument for measuring a quantitative outcome. J Med Lab Sci 1990, 4:57-60.
38. Lee J. Validation versus precision studies. J Med Lab Sci 1992, 6:44-5
39. Fleiss J L. Statistical Methods for Rates and Proportions 2nd ed New York: Wiley and Sons, 1981:212-36.
40. Lee J Confidence interval of the kappa coefficient by bootstrap resampling Psychiatry Res 1994, 49:97-8
41. Thomas D C, Siemiatycki J, Dewar R, Robins J, Goldberg M, Armstrong B G. The problem of multiple inference on studies designed to generate hypotheses Am J Epidemiol 1985, 122 1080-95.
42. Lee J, Chia K S, Lee H P. Regression analysis of biomedical research data based on a repeated measure or cluster sample. Ann Acad Med Singapore 1996, 25:129-33.
43. Liang K Y, Zeger S L Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-22.
44. Oldham P D. A note on the analysis of repeated measurements of the same subjects. J Chron Dis 1962, 15 969-77
45. Matthews J N S, Altman D G, Campbell M J, Royston P Analysis of serial measurements in medical research. BMJ 1990; 300:230-5.
46. Rose G Preventive cardiology: What lies ahead? Prev Med 1990; 19:97-104.